136 related articles for article (PubMed ID: 23288633)
21. Apoptosis and colorectal cancer: implications for therapy.
Yang SY; Sales KM; Fuller B; Seifalian AM; Winslet MC
Trends Mol Med; 2009 May; 15(5):225-33. PubMed ID: 19362056
[TBL] [Abstract][Full Text] [Related]
22. Molecular therapy of colorectal cancer: progress and future directions.
Weng W; Feng J; Qin H; Ma Y
Int J Cancer; 2015 Feb; 136(3):493-502. PubMed ID: 24420815
[TBL] [Abstract][Full Text] [Related]
23. Promising targets and drugs in development for colorectal cancer.
Thompson C; Leong S; Messersmith W
Semin Oncol; 2011 Aug; 38(4):588-97. PubMed ID: 21810518
[TBL] [Abstract][Full Text] [Related]
24. Targeting PI3K signaling as a therapeutic approach for colorectal cancer.
Zhang J; Roberts TM; Shivdasani RA
Gastroenterology; 2011 Jul; 141(1):50-61. PubMed ID: 21723986
[TBL] [Abstract][Full Text] [Related]
25. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer.
Jain VK; Hawkes EA; Cunningham D
Clin Colorectal Cancer; 2011 Dec; 10(4):245-57. PubMed ID: 21729675
[TBL] [Abstract][Full Text] [Related]
26. Targeted nanoparticles for colorectal cancer.
Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
[TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
[TBL] [Abstract][Full Text] [Related]
28. ApoG2 inhibits the antiapoptotic protein, Mcl‑1, and induces mitochondria‑dependent apoptosis in human colorectal cancer cells.
Li T; Yuan G; Zhang L; Ye L; Li S; Fan Y; Sun J
Mol Med Rep; 2015 Nov; 12(5):6976-84. PubMed ID: 26352605
[TBL] [Abstract][Full Text] [Related]
29. Novel targets for anticancer treatment development in colorectal cancer.
Macarulla T; Ramos FJ; Capdevila J; Saura C; Tabernero J
Clin Colorectal Cancer; 2006 Nov; 6(4):265-72. PubMed ID: 17241511
[TBL] [Abstract][Full Text] [Related]
30. Novel agents in the treatment of metastatic colorectal cancer.
Leong S; Messersmith WA; Tan AC; Eckhardt SG
Cancer J; 2010; 16(3):273-82. PubMed ID: 20526106
[TBL] [Abstract][Full Text] [Related]
31. Emerging drugs in refractory colorectal cancer.
Nobili S; Galletta A; Brugia M; Tassi R; Petreni P; Landini I; Mini E
Future Med Chem; 2015 Aug; 7(12):1491-501. PubMed ID: 26293581
[TBL] [Abstract][Full Text] [Related]
32. Search for novel target molecules for the effective treatment or prevention of colorectal cancer.
Tsujii M
Digestion; 2012; 85(2):99-102. PubMed ID: 22269287
[TBL] [Abstract][Full Text] [Related]
33. Novel drug discovery opportunities for colorectal cancer.
Curtin JC
Expert Opin Drug Discov; 2013 Sep; 8(9):1153-64. PubMed ID: 23768167
[TBL] [Abstract][Full Text] [Related]
34. Combinational treatment with microRNA‑133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFR.
Zhou J; Lv L; Lin C; Hu G; Guo Y; Wu M; Tian B; Li X
Mol Med Rep; 2015 Oct; 12(4):5407-14. PubMed ID: 26151111
[TBL] [Abstract][Full Text] [Related]
35. The promise of mTOR inhibitors in the treatment of colorectal cancer.
Kim DD; Eng C
Expert Opin Investig Drugs; 2012 Dec; 21(12):1775-88. PubMed ID: 22978346
[TBL] [Abstract][Full Text] [Related]
36. Perspectives on new chemotherapeutic agents in the treatment of colorectal cancer.
Clark JW
Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-19-S18-24. PubMed ID: 9420017
[TBL] [Abstract][Full Text] [Related]
37. Genetics of colorectal cancer.
Hisamuddin IM; Yang VW
MedGenMed; 2004 Aug; 6(3):13. PubMed ID: 15520636
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
Sartore-Bianchi A; Ardini E; Bosotti R; Amatu A; Valtorta E; Somaschini A; Raddrizzani L; Palmeri L; Banfi P; Bonazzina E; Misale S; Marrapese G; Leone A; Alzani R; Luo D; Hornby Z; Lim J; Veronese S; Vanzulli A; Bardelli A; Martignoni M; Davite C; Galvani A; Isacchi A; Siena S
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563355
[TBL] [Abstract][Full Text] [Related]
39. Epithelial-mesenchymal transition‑associated microRNAs in colorectal cancer and drug-targeted therapies (Review).
Jin D; Fang Y; Li Z; Chen Z; Xiang J
Oncol Rep; 2015 Feb; 33(2):515-25. PubMed ID: 25435189
[TBL] [Abstract][Full Text] [Related]
40. Integration of anti-epidermal growth factor receptor therapies with cytotoxic chemotherapy.
Serrano C; Markman B; Tabernero J
Cancer J; 2010; 16(3):226-34. PubMed ID: 20526101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]